Introduction {#s0005}
============

Porcine respiratory coronavirus (PRCV) is highly prevalent in pigs in Europe ([@b0075]) and in a serological survey in 2008 in Belgium, 698/728 samples tested positive for PRCV (unpublished data). The virus mainly infects the lower respiratory tract, targeting type-2 pneumocytes and, to a lesser extent, bronchiolar epithelium ([@b0005]). Although PRCV infection is typically sub-clinical or mild under experimental conditions, it can contribute to naturally occurring respiratory disease, when combined with other viruses or bacteria ([@b0015]).

Bacteria commonly colonise the lower respiratory tract during primary viral infection and their cell-wall components are also present in the dust generated within animal housing ([@b0025], [@b0035], [@b0190], [@b0195]). Some of the most important inflammatory components of the outer membrane of Gram-negative bacteria are lipopolysaccharides (LPS). PRCV acting in synergy with LPS from *Escherichia coli* induces severe respiratory disease with excessive production of pro-inflammatory cytokines, such as tumour necrosis factor (TNF)-α and interleukin (IL)-1 in the lungs ([@b0155]).

Gram-positive bacteria also release toxins such as lipoteichoic acids (LTA) that stimulate cytokine production ([@b0050]). Such bacteria and their cell-wall components can make up \>80% of the total bacterial content of the dust found in pig housing whereas Gram-negative organisms constitute only 2% ([@b0025], [@b0035]). *Staphylococcus* spp. are among the most widely distributed Gram-positive micro-organisms, and the LTA they produce share pathophysiological properties and recognition mechanisms such as CD14 and Toll-like receptors (TLRs), with LPS ([@b0050]). LTA from *S. aureus* has powerful cytokine-inducing activity both in vitro ([@b0095], [@b0065], [@b0030]) and in vivo in cattle ([@b0110]).

The objective of the present study was to assess whether LTA from *S. aureus* exacerbates disease and enhances pulmonary pro-inflammatory cytokine production in PRCV-infected pigs. It was anticipated that the cytokines examined might participate in the pathogenesis of disease (IL-1, IL-6, TNF-α) and/or in the immunological response to infection (interferon \[IFN\]-γ, IL-12/IL-23). We also evaluated if there was any correlation between the concentrations of the induced cytokines and the severity of clinical signs or pulmonary lesions.

Materials and methods {#s0010}
=====================

Virus and lipoteichoic acid preparation {#s0015}
---------------------------------------

A Belgian isolate of PRCV (91V44) was used on second passage in swine testis (ST) cells ([@b0145]); the inoculation dose was 10^7^ 50% tissue culture infective doses (TCID~50~)/pig. Based on previous experiments, the dose of LTA from *S. aureus* (Sigma--Aldrich) was 200 μg/kg bodyweight, which, in contrast to a 20 μg/kg dose, results in moderate to severe inflammatory cell infiltration (see [Appendix A, Supplementary material, Table 1](#s0090){ref-type="sec"}). In both doses there was no extensive cytokine production. The cytokine concentrations were higher than controls, but comparable with previous data using LPS alone and lower than in PRCV--LPS-inoculated animals ([@b0155], [@b0140]). Virus and LTA were diluted in pyrogen-free phosphate-buffered saline (PBS) (Gibco) to obtain 3 mL of inoculum.

Experimental design and sampling procedure {#s0020}
------------------------------------------

Twenty-eight, 3-week-old, caesarean-derived, colostrum-deprived pigs from four sows were individually housed in sterile, Horsefall-type isolation units with positive-pressure ventilation. The animals were fed commercial ultra-high-temperature-treated cow's milk. Twenty-four pigs were randomly assigned to three groups each containing eight animals.

All inoculations were performed via the intra-tracheal route as described previously ([@b0140]). One group was inoculated with PRCV and 24 h later with LTA (PRCV--LTA group). The remaining two groups were inoculated with either PRCV (PRCV group) or LTA (LTA group), respectively, and served as controls.

One pig from each group was euthanased by intra-peritoneal injection of pentobarbital (Kela Laboratories) at the time-points indicated ([Table 1](#t0005){ref-type="table"} ). The four remaining pigs were sham-inoculated with PBS and euthanased 4 h later. The experimental procedure had the authorisation of the Ethical and Animal Welfare Committee of the Faculty of Veterinary Medicine of Ghent University (EC 2004/40; EC 2005/75).Table 1Development of macroscopically visible pulmonary lesions and cytological changes within bronchoalveolar lavage fluid (BALF) of pigs following intra-tracheal inoculation of either porcine respiratory coronavirus (PRCV) only, lipoteichoic acid (LTA) only or a combination of PRCV followed 24 h later by LTA (PRCV--LTA).ParameterInoculation groupHours after PRCV/LTA inoculation27/328/429/532/836/1242/1848/2472/48Macroscopically visible lung lesions[a](#tblfn1){ref-type="table-fn"} (%)PRCV only00.11.30.60.39.56.05.0LTA only00000000PRCV--LTA2.02.30[b](#tblfn2){ref-type="table-fn"}1.00[b](#tblfn2){ref-type="table-fn"}4.02.68.5  Total BALF cells (×10^6^)PRCV only144173122142181305152138LTA only43055076037126083136235PRCV--LTA172294105331243223134163  Neutrophils in BALF (%)PRCV only2.31.93.96.35.14.73.33.4LTA only70.859.080.656.739.33.61.621.0PRCV--LTA10.931.24.745.416.611.46.24.2[^2][^3]

Post-mortem, bronchoalveolar lavage fluid (BALF) was collected from the right lung and cytological examination was carried out as previously described ([@b0140]). Tissue samples of approximately 1 cm^3^ were taken from the cranial, cardiac and diaphragmatic lobes of the left lung for virological and bacteriological examination. Virus titration was performed on 20% suspensions of pooled samples from the three lung lobes of each animal.

Clinical monitoring and scoring system {#s0025}
--------------------------------------

The pigs were clinically examined three times daily prior to and every hour after inoculation. Clinical 'scores' were allocated for: *respiratory rate* (0, \<60/min; 1, 60--90/min -- mild tachypnoea; 2, \>90/min -- severe tachypnoea); *laboured abdominal breathing* (0, absent; 1, present); *dyspnoea* (0, absent; 1, present); *depression* (0, absent; 1, present), and *anorexia* (0, absent; 1, present).

Anorexia was assessed by fasting the pigs for 6--8 h prior to inoculation and then providing each animal with 150--200 mL of milk following the inoculation procedure. Pigs that did not consume the milk were assigned an anorexia score of '1' (sham-inoculated animals had completely consumed their milk ration within 1 h). A fresh quantity of milk was given to each pig every 4 h to prevent bacterial spoilage influencing consumption. The total clinical score for each pig at each time-point was calculated by adding the scores for each clinical parameter.

Post-mortem assessment of lung lesions {#s0030}
--------------------------------------

Images of the macroscopically visible lesions were transcribed onto a lung diagram ([@b0020]) and the approximate percentage of the affected dorsal and ventral surfaces estimated. The percentage of lung affected was calculated as the average of the percentages of the affected dorsal and ventral surfaces.

Quantification of pro-inflammatory cytokines in BALF {#s0035}
----------------------------------------------------

Concentrations of IL-1, IL-6 and TNF-α were quantified in three separate bioassays and geometric means calculated ([@b0055], [@b0150]). IFN-γ was measured by ELISA (Biosource) and IL-12 using a DuoSet ELISA that detects the p40 sub-unit common to both IL-12 and IL-23 (R and D Systems). The assay did not discriminate between IL-12 and IL-23 ([@b0105], [@b0010], [@b0160]).

Virological and bacteriological examination {#s0040}
-------------------------------------------

Titres of PRCV were determined on ST cells ([@b0145]) with a detection limit of 10^1.7^ TCID~50~/g of tissue. Routine bacteriological examination of lung tissue was performed as follows. Samples were plated on bovine blood agar and cultured aerobically. A 'nurse'-colony of coagulase-positive *Staphylococcus* spp. was streaked diagonally on each plate. The plates were inspected for bacterial growth after 48 and 72 h. Colonies were identified by standard techniques as reported by [@b0135].

Statistical analysis {#s0045}
--------------------

Results of the three inoculation procedures were compared using the Friedman test with 'time of euthanasia' as a stratification factor. Pair-wise comparisons (PRCV--LTA vs. PRCV and PRCV--LTA vs. LTA) were carried out using the Wilcoxon signed-rank sum test also stratified using time of euthanasia. Pair-wise comparisons were tested at a comparison-wise significance level of 0.025 (Bonferroni corrected). Statistical analysis was performed using StatXact software.

Results {#s0050}
=======

Clinical signs and pulmonary viral load {#s0055}
---------------------------------------

No clinical signs were observed or virus found in the four sham-inoculated controls. [Fig. 1](#f0005){ref-type="fig"} illustrates the development of clinical signs in the experimental groups. Only 2/8 PRCV-only inoculated pigs developed mild depression and occasional anorexia 12--24 h post inoculation (PI), which persisted until 48 h PI. Of the eight LTA-only inoculated pigs, four developed mild (lasting \<1 h) depression and anorexia at 2 h (*n*  = 3) or at 8 h (*n*  = 1) PI, respectively. In contrast, the PRCV--LTA-inoculated animals exhibited severe tachypnoea, dyspnoea, laboured abdominal breathing, depression, anorexia and occasional vomiting. These signs were evident in 7/8 pigs by 1 h PI and had begun to resolve 4--8 h PI (clinical scores relating to individual animals are detailed in [Appendix A, Supplementary material, Table 3](#s0090){ref-type="sec"}).Fig. 1Development of mean clinical scores and the proportion of pigs exhibiting clinical signs in the group inoculated with both porcine respiratory coronavirus (PRCV) and lipoteichoic acid (LTA) (PRCV--LTA) (continuous line) compared to groups inoculated with either PRCV (long-dashed line) or LTA (short-dashed line). \* One animal from each group was euthanased from this time onwards. The *X* axis signifies hours after inoculation with PRCV (before the slash) and LTA (after the slash).

The three treatment groups differed significantly from each other (*P*  = 0.0014) when the maximum scores/pig in each group were compared. The PRCV--LTA group had a significantly higher maximum score than either the LTA (*P*  = 0.0156) or PRCV (*P*  = 0.0156) group.

Virus was detected in the lungs of all the PRCV-inoculated pigs. Titres were similar (*P*  = 1.00) in the PRCV (4.1--7.3 log~10~ TCID~50~/g tissue) and PRCV--LTA (4.8--8.0 log~10~ TCID~50~/g tissue) groups (individual animal titres detailed in [Appendix A, Supplementary material, Table 2](#s0090){ref-type="sec"}). Virus was not detected in animals in the LTA group. No bacteria were cultured from any of the lungs from any group.

Assessment of lung lesions and cytological examination of BALF {#s0060}
--------------------------------------------------------------

Grossly visible red regions of consolidation were scattered predominantly throughout the cranial and cardiac lobes of the PRCV-only and PRCV--LTA inoculated groups. [Table 1](#t0005){ref-type="table"} details the percentages of affected lung area, BALF cell counts and neutrophil influx as percent of BALF cells. Lesions were not observed in the sham-inoculated animals. The BALF cell count and the neutrophil percentages in these pigs ranged from 34 to 161 × 10^6^ and from 0% to 0.9%, respectively.

In the PRCV-only group, pulmonary lesions were seen in \<=9.5% of the lung surface area. The total BALF cell count and neutrophil percentage also remained constant despite individual animal variation. Although the LTA group did not exhibit lesions, the total BALF cell count in 6/8 of these pigs and the neutrophil percentage in all eight animals exceeded the maximal values observed in sham-inoculated controls. The PRCV--LTA group developed lung lesions 27 h after PRCV inoculation but the overall pattern of lesion development did not differ from that of the PRCV-only group (*P*  = 1.0).

The total BALF cell counts did not differ significantly between either the PRCV--LTA and PRCV groups (*P*  = 0.25), or between the PRCV--LTA and LTA groups (*P*  = 0.078). The percentage of neutrophils in BALF in the PRCV--LTA group, while significantly higher than in the PRCV group (*P*  = 0.0078), was not significantly different from that in the LTA group (*P*  = 0.039).

Quantification of pro-inflammatory cytokines in BALF {#s0065}
----------------------------------------------------

The concentrations of pro-inflammatory cytokines in BALF are illustrated in [Fig. 2](#f0010){ref-type="fig"} . No TNF-α, IL-6 or IL-12/IL-23 were detected in any of the sham-inoculated controls. Only low levels of IL-1 (102 and 96 U/mL) and IFN-γ (10 and 12 pg/mL) were detected in 2/4 of the sham-inoculated controls. Inoculation of PRCV alone induced higher levels of IL-6 (4662--46,353 U/mL), IL-12/IL-23 (11--121 pg/mL) and TNF-α (124--545 U/mL) than in the sham-inoculated pigs, and the concentrations of IL-1 (\<40--544 U/mL) and IFN-γ (0--2329 pg/mL) in 6/8 of the PRCV-inoculated animals were higher than the highest levels recorded in the sham-inoculates.Fig. 2The concentrations of various cytokines in the bronchoalveolar lavage fluid of pigs in the porcine respiratory coronavirus (PRCV) and lipoteichoic acid (LTA)-inoculated group (PRCV--LTA) (triangles), and in groups given either PRCV (diamonds) or LTA (squares). The concentrations in the four sham-inoculated controls are represented as circles at time-point 0/0. The *X* axis signifies hours after inoculation with PRCV (before the slash) and LTA (after the slash).

Inoculation of LTA alone resulted in the induction of IL-1, IL-6 and TNF-α for a short period. By 12 h PI, these cytokines were no longer detectable in these pigs. The concentrations of IFN-γ in this group never exceeded those in sham-inoculated animals and remained constant throughout the experiment. The levels of IL-12/IL-23 in 3/8 LTA-inoculated animals exceeded the maximal levels observed in the sham-inoculates. Cytokine concentrations were similar in the PRCV--LTA and PRCV groups (*P*  \> 0.025), and the levels of IL-6, IL-12/IL-23 and IFN-γ were higher than those of the LTA group (*P*  \< 0.025). The concentrations of all cytokines peaked at 28/4 h after PRCV/LTA inoculation and at the end of the study the levels were still higher than in the sham-inoculated controls.

Discussion {#s0070}
==========

The results of this experiment demonstrate that LTA from *S. aureus* enhances the clinical severity of PRCV infection in pigs in a manner similar to that of LPS from *E. coli* ([@b0155]). However, there was no evidence that this clinical exacerbation was associated with over-production of pro-inflammatory cytokines such as TNF-α, as previously hypothesised in the context of PRCV infection and LPS ([@b0155]). The concentration of TNF-α was higher in PRCV--LPS-inoculated relative to PRCV- and LPS-inoculated controls, and there was a temporal association between peak TNF-α production and the severity of clinical signs. Other cytokines, in addition to TNF-α, were elevated in PRCV--LTA-inoculated pigs and there was no significant difference in the concentration of this cytokine between the PRCV-only and the PRCV--LTA groups.

Differences in the modes of action of LTA and LPS may relate to the different ways these compounds are recognised by the host ([@b0040]). It is likely that LTA is recognised by TLR-2 ([@b0060], [@b0070], [@b0090]), whereas LPS recognition is mediated through TLR-4 ([@b0130]). Pure LTA appears to be a less potent cytokine-inducer than LPS and the ability of LTA to induce higher concentrations of cytokines has been attributed to its synergistic interactions with other bacterial components such as muramyl dipeptide ([@b0180]), peptidoglycan or host macromolecules such as glycosphingolipids ([@b0090]).

Recently, the recognition of LTA has been shown to involve not only TLR-2 and CD14 (also a co-receptor for LPS), but also CD36. Blocking of this co-receptor and CD14 inhibited the binding of LTA and LTA-induced TNF-α release by human monocytes ([@b0100]). Further research is required to determine if PRCV infection induces increased expression of LTA receptors such as TLR-2 and CD36, as has been shown for CD14 ([@b0140]). In general, the mechanisms through which Gram-positive bacteria effect host immunological activation are less clearly understood than for Gram-negative infections ([@b0115], [@b0040]).

In general, bacterial cell-wall components are effective in inducing the production of chemokines such as IL-8. Our finding that up to 81% of the total BALF cells were neutrophils in LTA-inoculated pigs indicates that this bacterial component may be highly effective in activating pulmonary neutrophil infiltration in this species. A similar rapid influx of neutrophils into the milk of cows occurs following inoculation of 10--100 μg LTA into the mammary gland ([@b0110]). In this study the neutrophil influx was accompanied by increased secretion of TNF-α and IL-1β and of chemokines like CXCL-2 and IL-8. In the current study, the finding that the total BALF cell count and neutrophil percentages in the PRCV--LTA pigs were slightly, though not significantly, lower than in LTA-inoculated animals during the first 8 h PI may possibly have been due to their more rapid and effective destruction in the dually-inoculated pigs ([@b0085], [@b0045], [@b0185]).

We did not investigate the possible role of histamine in the pathogenesis of disease in our experimental model. In addition to mast cells, neutrophils can produce histamine during mycoplasma infection in mice ([@b0175]). Histamine can interact with LPS in the expression of cyclo-oxygenase-2 and of prostaglandin I~2~ and E~2~ by human endothelial cells ([@b0125]) and can also increase the sensitivity of these cells to the effects of Gram-positive and Gram-negative bacteria through inducing the expression of TLR-2, TLR-4 ([@b0120]), IL-8 and IL-6 ([@b0080]). Furthermore, histamine-mediated respiratory disease closely resembles the pattern of clinical signs observed in our study ([@b0165], [@b0170]).

Histamine causes broncho-constriction leading to dyspnoea, tachypnoea and laboured abdominal breathing. Moreover, its ability to induce the production of TNF-α, IL-6 and other cytokines may also contribute to the severity of these clinical features. Leaving aside this speculation as to a possible role for histamine in our infection model, we can conclude that the severity of the induced disease was not linked to the effect of TNF-α, but most likely reflected an integrated, concerted interaction between the examined cytokines and possibly other (so far unidentified) mediators.

Conclusions {#s0075}
===========

To our knowledge this is the first in vivo study to report the synergistic interaction between a virus and LTA in enhancing the severity of respiratory disease in the pig. Given that Gram-positive bacteria capable of producing LTA are commonly found in high quantities in the dust within pig accommodation, its role in the development of porcine respiratory disease complex merits further investigation.
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[^1]: Present address: Communicable and Infectious Diseases, Scientific Institute of Public Health, Engelandstraat 642, B-1180 Brussels, Belgium.

[^2]: Macroscopically visible lesions were calculated as the mean of the percentage of affected dorsal and ventral lung surfaces.

[^3]: Minimal lesions representing \<0.05% of the total lung surface.
